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Bacterial biofilms account for more than 80% of hu-
man infections. Hergenrother and coworkers report in
this issue that high concentrations of iron salts can
block the formation of these bacterial communities
[1]; this represents an attractive new method for bio-
film control.
Bacteria are not always solitary little beasts—rather,
they have the ability to organize and work as a group
to benefit their cause. In order to decide when to make
this lifestyle switch, bacteria continually assess their
population densities by using a process called quorum
sensing. When a sufficient number of bacteria (a “quo-
rum”) are present, they alter gene expression to carry
out processes that necessitate the cooperation of a
large number of cells [2, 3]. Virulence-factor production
and biofilm formation in certain pathogens, for exam-
ple, are under the direct control of quorum sensing.
Therefore, population density plays a critical role in
pathogenesis [4]. This makes sense; the chances of a
successful attack on a host are far higher with a “mob”
of bacteria as opposed to a small, polite gathering.
New approaches are required to treat bacterial infec-
tions, and quorum sensing has become an attractive
target [5]. Biofilms are of particular interest because
these bacterial communities are involved in more than
80% of all human infections [6]. For example, chronic
biofilm lung infections by the Gram-negative pathogenPseudomonas aeruginosa are the primary cause of
morbidity in cystic fibrosis (CF) [4, 7]. The development
of small molecules that inhibit quorum sensing and bio-
film formation has received much recent attention [8,
9]. In this issue of Chemistry & Biology, the Hergen-
rother lab marks an advance in this field through the
discovery that high doses of simple iron salts can block
biofilm formation in P. aeruginosa [1]. Not only does
iron block biofilm formation, but the metal ion can also
disrupt preexisting biofilms. This is a significant result
because biofilms are notoriously resistant to both im-
mune-system attack and antimicrobial agents [10, 11].
The main findings of this report are highlighted here.
At the outset of their work, Musk et al. screened an
approximately 4000-member small-molecule library for
compounds that inhibited P. aeruginosa biofilm forma-
tion. They utilized a novel 384-well-plate static-biofilm
assay to expedite the screening process and uncov-
ered several hits. Interestingly, the salt ferric ammonium
citrate (FAC) was found to be the most active and ex-
hibited dose-dependent inhibition of P. aeruginosa bio-
film formation (IC50z 60 M). The counter ions, ammo-
nium citrate along with others, were found to be
inactive, indicating that iron itself [most likely Fe(III)]
was the active inhibitor. This was a surprising result for
two reasons: (1) FAC was found in a library composed
almost entirely of drug-like organic compounds, and (2)
this result contrasts directly with previous data indicat-
ing that very low iron concentrations (i.e., iron starva-
tion) can inhibit biofilm formation [12]. This discovery
underscores the value of screening-based approaches
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rrequires more critical examination. Importantly, high
levels of FAC were not found to affect bacterial growth. r
vA briefing on biofilms is useful here. Biofilms are de-
fined as sessile communities of bacteria encased in a i
cself-generated exopolysaccharide matrix [10]—forma-
tion of this slimy coat is under the control of quorum a
asensing (Figure 1). These communities commonly form
on solid surfaces exposed to a continuous flow of nutri- i
vents. For example, biofilms persistently colonize in-dwell-
ing medical devices, such as catheters, stents, and venti- h
ilators. They are also a primary cause of biofouling in
industrial and marine settings [14]. The compact nature
iof biofilms, the reduced metabolic rates of their outer
strata, and the physical protection conferred by their s
tpolymeric coats render these colonies resistant to most
antibiotics and, therefore, difficult to eradicate [10]. b
tWith this latter challenge in mind, Musk et al. astutely
probed the antibiotic resistance of 2-day-old P. aerugi- t
wnosa biofilms in the presence of FAC and found that
the sensitivity of the biofilm to the antibiotic tobramycin o
tincreased with increasing FAC concentration. Next, the
authors introduced FAC into flow-chamber devices a
containing 5-day-old P. aeruginosa biofilms and ob-
served the complete clearance of the biofilms after an e
aadditional 5 days. This is a major finding because it
means iron could be used to treat previously formed 1
rbiofilms, not just prevent their formation. Indeed, few
chemical treatments to mitigate biofilm formation, at b
gany stage of growth, are known [15].
Musk et al. then used multiple techniques, including c
bfluorescence microscopy, assays of twitching motility,
and detailed time-course experiments, to collect sub- n
stantial additional data that supported FAC’s ability to
inhibit biofilm formation. To investigate the effects of H
FAC on different and clinically relevant P. aeruginosa D
strains, the authors used FAC to treat clinical isolates U
of P. aeruginosa from CF patients. They found that FAC 1
strongly inhibited biofilm formation in the majority of M
these strains. In view of the prominent role of P. aerugi-
nosa infections in the progression of CF (see above),
this last set of data is exceptional. Of note, the high S
FAC concentration (ca. 250 M) required for inhibition
in these experiments does raise some concerns for
clinical usage. Additional studies of the effects of pH
and counter ions on iron (III) solubility and activity could
be beneficial in this arena.
The next challenge is to determine just how iron is
inhibiting biofilm formation. The author’s data, along
with those of others [12], have revealed that biofilm for-
mation in P. aeruginosa can occur over a range of iron
concentrations (ca. 1–100 M), above and below which
the organism can exist in only a planktonic state. A min-
imum level of iron is required simply for bacterialFigure 1. Schematic of the Bacterial-Biofilm
Formation Process and Its Inhibition by High
Concentrations of Iron
The biofilm is depicted as a cut-away image.growth, however. Transcriptional profiling studies havehown that low and high iron concentrations induce or
epress a number of genes involved in iron acquisition,
espectively [16, 17]. The bulk of these genes are in-
olved in the biosynthesis of two siderophores (metal-
on chelators), pyochelin and pyoverdin, that are impli-
ated in the scavenging of iron. Intriguingly, pyoverdin
lso signals for the production of virulence factors that
re critical for pathogenesis. In addition, low levels of
ron have been connected to enhanced P. aeruginosa
irulence in CF [18]. And, to bring this story full circle,
igh levels of iron have been shown to repress genes
nvolved in quorum sensing in P. aeruginosa [16].
In light of these data, the authors thus speculate that
ron-replete conditions could be suppressing quorum
ensing in P. aeruginosa and that this suppression in
urn inhibits the production and/or upkeep of bacterial
iofilms (Figure 1). Clearly, further studies are required
o elucidate the complex roles of iron in biofilm forma-
ion and pathogenesis. In the short term, however, it
ould be interesting to examine the effects of iron on
ther Gram-negative bacteria prone to biofilm forma-
ion because quorum sensing circuits in these species
re highly homologous [3].
The work of Hergenrother and coworkers provides an
ffective new method to eradicate bacterial biofilms. It
lso shows, in combination with other recent work [8,
3, 19], that chemists are poised to play an important
ole in this research area. The ease with which iron can
e applied to and released from different surfaces sug-
ests many immediate clinical and environmental appli-
ations for this research. As for the bacteria dwelling in
iofilms, however, these research findings surely will be
o crowd pleaser.
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